Atypical stromal cells are rarely identified in the endometrial polyps of the female lower genital system. These cells are suggested to develop due to a degenerative or reactive phenomenon. And osteoclastic like giant cells, which have been reported in many epithelial and mesenchymal tumors of uterus, may develop because of a degenerative or a reactive process. In this case report, we present a breast cancer patient who was commenced on Tamoxifen treatment presenting with formation of both atypical stromal cells in an endometrial polyp and osteoclastic like giant cells in the leiomyoma of the uterus. Patients who are treated with Tamoxifen should be followed meticulously to detect tumoral or proliferative lesions of endometrium and myometrium because of the adverse effects of tamoxifen on uterus. (www.actabiomedica.it).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233774PMC
http://dx.doi.org/10.23750/abm.v90i4.7746DOI Listing

Publication Analysis

Top Keywords

stromal cells
12
osteoclastic giant
12
giant cells
12
case report
8
cells endometrial
8
endometrial polyp
8
polyp osteoclastic
8
cells leiomyoma
8
atypical stromal
8
develop degenerative
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!